By AuntMinnieEurope.com staff writers

September 27, 2017 -- Imaging software developer Mirada Medical has signed a three-year master service agreement with international healthcare firm BTG for multiple projects to support BTG's portfolio of interventional medicine products.

Mirada and BTG have been collaborating since October 2015 to develop software to optimize radioembolization therapy with radioisotope firm Nordion's TheraSphere yttrium-90 glass microsphere treatment for liver cancer.

That collaboration resulted in Simplicit90Y, customized dosimetry software designed to help physicians personalize treatment with Y-90 therapies, such as TheraSphere.

The Simplicit90Y software received CE Mark certification in Europe in October 2016.


Copyright © 2017 AuntMinnieEurope.com
 

To read this and get access to all of the exclusive content on AuntMinnieEurope.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnieEurope.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: